The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
CONFIRMED84% CONFIDENCELilly's release is datelined "HOUSTON[4], Sept. 21, 2026" and says Lilly "broke ground today in Houston, Texas[6]"; Community Impact[2] reports the groundbreaking ceremony was held Sept. 21.
A 236-acre plant that will make the active ingredient of Lilly's Foundayo weight-loss pill, with more than 600 permanent jobs and about 4,000 construction jobs. Lilly expects it running by 2030.